SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 192.82 |
| Enterprise Value ($M) | 126.37 |
| Book Value ($M) | 203.13 |
| Book Value / Share | 3.06 |
| Price / Book | 0.95 |
| NCAV ($M) | 100.99 |
| NCAV / Share | 1.52 |
| Price / NCAV | 1.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.83 |
| Current Ratio | 6.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 272.62 |
| Assets | 374.76 |
| Liabilities | 171.63 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.90 |
| Operating Income | -138.56 |
| Net Income | -126.61 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -52.74 |
| Cash from Investing | -9.70 |
| Cash from Financing | 35.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 10.50 | -4.61 | |
| 13G/A | Bb Biotech Ag | 5.50 | 0.00 | |
| 13G/A | Fmr Llc | 8.10 | -18.45 | |
| 13G/A | Atlas Venture Fund X, L.P. | 10.80 | 0.00 | |
| 13G/A | BlackRock Inc. | 4.80 | -14.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 10,832 | 107,698 | 10.06 | |
| 15,381 | 37,363 | 41.17 | |
| 19,895 | 75,117 | 26.49 | |
| 20,334 | 50,962 | 39.90 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FGEN – FibroGen, Inc. | FNCH – Finch Therapeutics Group, Inc. |
| FUSN – Fusion Pharmaceuticals Inc. | GERN – Geron Corporation |
| GILD – Gilead Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io